Nuvalent Ownership | Who Owns Nuvalent?


OverviewForecastFinancialsChart

Nuvalent Ownership Summary


Nuvalent is owned by 107.37% institutional investors, 3.12% insiders. Deerfield management company, l.p. (series c) is the largest institutional shareholder, holding 27.39% of NUVL shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 3.52% of its assets in Nuvalent shares.

NUVL Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockNuvalent107.37%3.12%-10.50%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Deerfield management company, l.p. (series c)17.99M27.39%$1.41B
Fmr9.65M14.70%$755.74M
Paradigm biocapital advisors lp5.36M8.17%$419.85M
Vanguard group4.50M6.85%$352.25M
Blackrock funding, inc. /de3.85M5.86%$301.50M
Blackrock3.02M4.71%$229.37M
Perceptive advisors2.62M3.99%$205.09M
Commodore capital lp1.62M2.47%$126.94M
Bain capital life sciences investors1.45M2.20%$113.29M
State street1.33M2.07%$100.59M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Deerfield management company, l.p. (series c)17.99M26.67%$1.41B
Paradigm biocapital advisors lp5.36M14.61%$419.85M
Bain capital life sciences investors1.45M13.33%$113.29M
Fairmount funds management1.32M10.25%$103.15M
Commodore capital lp1.62M9.30%$126.94M
Silverarc capital management400.01K6.85%$31.31M
Artia global partners lp204.04K5.71%$15.97M
Perceptive advisors2.62M5.65%$205.09M
Boxer capital1.12M4.48%$84.98M
First turn management309.52K4.34%$24.23M

Top Buyers

HolderShares% AssetsChange
Commodore capital lp1.62M9.30%681.60K
Vestal point capital, lp600.00K2.78%600.00K
Adage capital partners gp680.00K0.09%400.00K
Vanguard group4.50M0.01%366.24K
Paradigm biocapital advisors lp5.36M14.61%363.38K

Top Sellers

HolderShares% AssetsChange
Deerfield management company, l.p. (series c)17.99M26.67%-2.00M
Darwin global management---1.44M
Bain capital life sciences investors1.45M13.33%-1.25M
Fairmount funds management1.32M10.25%-369.40K
Perceptive advisors2.62M5.65%-359.26K

New Positions

HolderShares% AssetsChangeValue
Vestal point capital, lp600.00K2.78%600.00K$46.97M
Norges bank318.74K0.00%318.74K$24.95M
Polar capital287.50K0.13%287.50K$21.81M
Braidwell lp241.24K0.56%241.24K$18.88M
American century companies186.38K0.01%186.38K$14.59M

Sold Out

HolderChange
Financial gravity asset management-1.00
Massmutual trust co fsb/adv-8.00
Lynx investment advisory-15.00
Nelson, van denburg & campbell wealth management group-16.00
Continuum advisory-28.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20242268.65%70,521,6170.93%1070.95%14217.36%49-10.91%
Sep 30, 202420816.85%69,868,5036.54%1061.02%12224.49%54-
Jun 30, 2024178-3.78%65,581,7903.58%1021.05%98-8.41%54-6.90%
Mar 31, 20241859.47%63,315,326-0.47%980.83%107-10.83%58141.67%
Dec 31, 202316936.29%63,616,71713.92%1091.14%12071.43%24-22.58%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl O2.49M3.52%-
Fidelity Growth Compy Commingled Pl S2.41M3.37%-334.72K
Fidelity Growth Company Fund1.75M2.45%-80.00K
Vanguard Total Stock Mkt Idx Inv1.47M2.05%1.08K
Vanguard Small Cap Index1.17M1.64%989.00
iShares Russell 2000 ETF927.16K1.29%-8.03K
Vanguard Small Cap Value Index Inv772.44K1.08%-2.56K
Fidelity Select Health Care670.00K0.94%-
SPDR® S&P Biotech ETF627.16K0.88%-6.72K
Vanguard Institutional Extnd Mkt Idx Tr584.78K0.82%848.00

Recent Insider Transactions


DateNameRoleActivityValue
Mar 27, 2025Noci Darlene Chief Development OfficerSell$66.45K
Mar 27, 2025Noci Darlene Chief Development OfficerSell$226.02K
Mar 17, 2025Porter James Richard President and CEOSell$755.61K
Mar 17, 2025Porter James Richard President and CEOSell$1.25M
Mar 17, 2025Porter James Richard President and CEOSell$46.09K

Insider Transactions Trends


DateBuySell
2025 Q1-41
2024 Q4-33
2024 Q3-73
2024 Q2-51
2024 Q1-17

NUVL Ownership FAQ


Who Owns Nuvalent?

Nuvalent shareholders are primarily institutional investors at 107.37%, followed by 3.12% insiders and -10.49% retail investors. The average institutional ownership in Nuvalent's industry, Biotech Stocks , is 68.48%, which Nuvalent exceeds.

Who owns the most shares of Nuvalent?

Nuvalent’s largest shareholders are Deerfield management company, l.p. (series c) (17.99M shares, 27.39%), Fmr (9.65M shares, 14.70%), and Paradigm biocapital advisors lp (5.36M shares, 8.17%). Together, they hold 50.26% of Nuvalent’s total shares outstanding.

Does Blackrock own Nuvalent?

Yes, BlackRock owns 4.71% of Nuvalent, totaling 3.02M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 229.37M$. In the last quarter, BlackRock increased its holdings by 315.17K shares, a 11.64% change.

Who is Nuvalent’s biggest shareholder by percentage of total assets invested?

Deerfield management company, l.p. (series c) is Nuvalent’s biggest shareholder by percentage of total assets invested, with 26.67% of its assets in 17.99M Nuvalent shares, valued at 1.41B$.

Who is the top mutual fund holder of Nuvalent shares?

Fidelity Growth Compy Commingled Pl O is the top mutual fund holder of Nuvalent shares, with 3.52% of its total shares outstanding invested in 2.49M Nuvalent shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools